CBOE insiders dump $4.36 M in shares as stock nears 52‑week high

Over the twelve‑month period ending May 25 2026, Cboe Global Markets, Inc. (CBOE) recorded zero insider purchases and six sales amounting to $4,357,075. Five distinct insiders were involved, all of whom are senior executives or board members. The absence of buying activity pushes the buy‑to‑sell ratio to 0.00x, a level that typically flags heavy insider selling. While insider sales can stem from routine equity compensation or diversification, the concentration of large transactions in this case warrants closer scrutiny.

The chief operating officer, Christopher A. Isaacson, accounted for the largest portion of the outflow, selling two blocks of 5,000 shares each for $1,183,300 on September 2 2025 and $1,106,850 on June 9 2025, together representing $2,290,150 or 52% of total insider sales. Among directors, Edward J. Fitzpatrick disposed of 3,947 shares for $1,128,329 on February 18 2026, while Janet P. Froetscher and Alexander JR. Matturri sold $437,944 and $428,040 respectively in the same year. The remaining $72,612 came from another C‑suite officer, a modest amount relative to the overall outflow.

Monthly activity highlights two spikes: February 2025 saw $4,196,822 in sales, and September 2024 recorded $1,575,361. Those two months alone represent over 80% of the total $4.36 M sold by insiders. No clustering of purchases occurred, and the only clustering of sales involved three directors within a 30‑day window in February 2026, a pattern that, while not as strong as coordinated buying, still signals a collective move to reduce exposure.

The market context amplifies the significance of the selling. CBOE’s share price sits at $357.57, up 1.60% on the day and delivering a 42.4% gain year‑to‑date. Technical indicators show an RSI of 62 and a position at 91% of the 52‑week range, indicating the stock is trading near its recent high. Insiders often liquidate positions when valuations peak, converting paper gains into cash. The scale of the COO’s sales, combined with the directors’ sizable disposals, suggests that senior management may be capitalizing on the current premium.

Investors should weigh the material insider outflow against the strong price performance. While the sales could simply reflect pre‑planned equity awards vesting, the lack of any insider buying and the concentration of large sales in a narrow time frame provide a cautionary signal. Monitoring future filings for any reversal—particularly any coordinated buying by senior executives—will be essential to gauge whether the current selling trend is an isolated profit‑taking episode or the beginning of a broader shift in insider sentiment.